Transcriptional networks in the liver: Hepatocyte nuclear factor 6 function is largely independent of Foxa2

被引:42
作者
Rubins, NE
Friedman, JR
Le, PP
Zhang, LP
Brestelli, J
Kaestner, KH
机构
[1] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA
[3] Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA
关键词
D O I
10.1128/MCB.25.16.7069-7077.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A complex network of hepatocyte nuclear transcription factors, including HNF6 and Foxa2, regulates the expression of liver-specific genes. The current model, based on in vitro studies, suggests that HNF6 and Foxa2 interact physically. This interaction is thought to synergistically stimulate Foxa2-dependent transcription through the recruitment of p300/CBP by HNF6 and to inhibit HNF6-mediated transcription due to the interference of Foxa2 with DNA binding by HNF6. To test this model in vivo, we utilized hepatocyte-specific gene ablation to study the binding of HNF6 to its targets in the absence of Foxa2. Chromatin immunoprecipitation using anti-HNF6 antibodies was performed on chromatin isolated from Foxa2(loxP/lox-P) Alfp.Cre and control mouse livers, and HNF6 binding to its target, Glut2, was determined by quantitative PCR. In contrast to the current model, we found no significant difference in HNF6 occupancy at the Glut2 promoter between Foxa2-deficient and control livers. In order to evaluate the Foxa2/HNF6 interaction model on a global scale, we performed a location analysis using a microarray with 7,000 mouse promoter fragments. Again, we found no evidence that HNF6 binding to its targets in chromatin is reduced in the presence of Foxa2. We also examined the mRNA levels of HNF6 targets in the liver using a cDNA array and found that their expression was similar in Foxa2-deficient and control mice. Overall, our studies demonstrate that HNF6 binds to and regulates its target promoters in vivo in the presence and absence of Foxa2.
引用
收藏
页码:7069 / 7077
页数:9
相关论文
共 25 条
[1]   A transcription factor regulatory circuit in differentiated pancreatic cells [J].
Boj, SF ;
Párrizas, M ;
Maestro, MA ;
Ferrer, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (25) :14481-14486
[2]   Liver-enriched transcription factors and hepatocyte differentiation [J].
Cereghini, S .
FASEB JOURNAL, 1996, 10 (02) :267-282
[3]   Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4 [J].
Cirillo, LA ;
Lin, FR ;
Cuesta, I ;
Friedman, D ;
Jarnik, M ;
Zaret, KS .
MOLECULAR CELL, 2002, 9 (02) :279-289
[4]  
Clotman F, 2002, DEVELOPMENT, V129, P1819
[5]   Synergistic action of hepatocyte nuclear factors 3 and 6 on CYP2C12 gene expression and suppression by growth hormone-activated -: STAT5b proposed model for female-specific expression of CYP2C12 in adult rat liver [J].
Delesque-Touchard, N ;
Park, SH ;
Waxman, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (44) :34173-34182
[6]   A genetic switch in pancreatic β-cells -: Implications for differentiation and haploinsufficiency [J].
Ferrer, J .
DIABETES, 2002, 51 (08) :2355-2362
[7]   Orthogonal analysis of C/EBP β targets in vivo during liver proliferation [J].
Friedman, JR ;
Larris, B ;
Le, PP ;
Peiris, TH ;
Arsenlis, A ;
Schug, J ;
Tobias, JW ;
Kaestner, KH ;
Greenbaum, LE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (35) :12986-12991
[8]   CCAAT enhancer-binding protein β is required for normal hepatocyte proliferation in mice after partial hepatectomy [J].
Greenbaum, LE ;
Li, W ;
Cressman, DE ;
Peng, Y ;
Ciliberto, G ;
Poli, V ;
Taub, R .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (05) :996-1007
[9]   Hepatic specification of the gut endoderm in vitro: Cell signaling and transcriptional control [J].
Gualdi, R ;
Bossard, P ;
Zheng, MH ;
Hamada, Y ;
Coleman, JR ;
Zaret, KS .
GENES & DEVELOPMENT, 1996, 10 (13) :1670-1682
[10]   HNF-4α:: from MODY to late-onset type 2 diabetes [J].
Gupta, RK ;
Kaestner, KH .
TRENDS IN MOLECULAR MEDICINE, 2004, 10 (11) :521-524